Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review standards.

A CDC panel’s vote to stop recommending thimerosal-containing flu shots would have limited impact, but it illustrates how the ...

The Trump administration's vaccine advisers have brought up an old flu-shot debate: Whether it's time to wipe out the last ...

Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...

U.S. Health Secretary Robert F. Kennedy Jr’s newly appointed Advisory Committee on Immunization Practices (ACIP) upheld ...

U.S. Health Secretary Robert F. Kennedy Jr.’s new vaccine advisory committee endorsed fall flu vaccinations Thursday for just ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

The CDC's newly rebuilt Advisory Committee on Immunization Practices (ACIP) took aim Thursday at a mercury-based preservative long targeted by vaccine skeptics, recommending that children, pregnant ...

News of the cancellation came as Moderna revealed positive interim data from a phase 1/2 trial of its pandemic influenza vaccine, mRNA-1018, which targets the H5N8 bird flu subtype as well as ...

As America grapples with one of the worst flu outbreaks in recent years, researchers are hoping to close in on a stronger ...